Business
GE HealthCare’s Photonova Spectra photon-counting CT receives FDA clearance
FDA clearance quickly follows Photonova Spectra’s debut at the Radiological Society of North America (RSNA) 2025 Annual Meeting, marking rapid momentum for
About this update from Ge Healthcare Technologies Inc.
[{"type":"text","content":"\n\nFDA clearance quickly follows Photonova Spectra’s debut at the Radiological Society of North America (RSNA) 2025 Annual Meeting, marking rapid momentum for GE HealthCare’s innovative photon-counting CT technology\n\n\n\nPhotonova Spectra introduces the next generation of spectral photon-counting CT technology with 8‑bin energy resolution, powered by GE HealthCare’s proprietary Deep Silicon detector technology and a one‑scan universal workflow designed to boost efficiency and reduce complexity across a wide range of CT exams\n\n\n\nPhotonova Spectra is a result of the company’s $5.1 billion innovation investment, leading to a wave of transformational products across the portfolio which combined are expected to drive 1-2% revenue growth\n\n\n\n CHICAGO--(BUSINESS WIRE)--\nGE HealthCare (Nasdaq: GEHC) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Photonova™ Spectra,i an innovative photon‑counting computed tomography (PCCT) solution powered by the company’s novel Deep Silicon detector technology and offered as a flexible platform with multiple configurations to meet diverse clinical needs. With wide coverage and the combination of ultra-high definition (UHD) spatial and spectral imaging, Photonova Spectra helps enable fast acquisition speeds and the precise visualization of subtle tissue variations, small lesions and vascular structures.\n\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323095678/en/GE HealthCare’s Photonova Spectra photon-counting CT receives FDA clearance\nPhoton-counting CT represents a significant advancement in medical imaging. Unlike conventional CT systems – which first convert X-ray photons into visible light before measuring them – photon-counting CT directly counts individual photons and measures their energy. This approach enables higher spectral and spatial resolution as well as improved tissue characterization, helping provide clinicians with rich information to detect and diagnose disease with confidence.\n\n\n“As clinicians across the United States face rising volumesii and increasing diagnostic complexity, iii technology must do more than capture images; it must simplify decision-making and strengthen performance across the enterprise,” says Catherine Estrampes, President & CEO, U.S. and Canada, ...